Stock Events

Stock Events

Aquestive Therapeutics 

$5.34
122
-$0.01-0.19% 19:59 Today
+$0.05+0.94%22:23After hours

Statistics

Day High
5.49
Day Low
5.3
52W High
7.55
52W Low
2.93
Volume
2,115,756
Avg. Volume
2,654,501
Mkt Cap
670.23M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

9NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.24
-0.18
-0.13
-0.07
Expected EPS
-0.12
Actual EPS
N/A

Financials

-188.09%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
44.55MRevenue
-83.78MNet Income

Analyst Ratings

10.00Average Price Target
The highest estimate is 10.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AQST. It's not an investment recommendation.
Microsoft
22
MSFT
Amazon
22
AMZN
NVIDIA
22
NVDA
Apple
21
AAPL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb competes in the pharmaceuticals space, offering a range of drugs that could compete with Aquestive's treatments in various therapeutic areas.
Pfizer
PFE
Mkt Cap159.36B
Pfizer operates in similar therapeutic areas as Aquestive, making it a direct competitor in the pharmaceutical market.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its pharmaceutical division Janssen, competes in the development and marketing of drugs that could overlap with Aquestive's product offerings.
Merck
MRK
Mkt Cap366B
Merck & Co. offers a broad portfolio of drugs, including those in the therapeutic areas that Aquestive targets, making them a competitor.
Novartis
NVS
Mkt Cap292.35B
Novartis is a global healthcare company that competes with Aquestive in the research, development, and marketing of pharmaceutical products.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie operates in many of the same therapeutic areas as Aquestive, with a strong focus on research-based pharmaceuticals.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences is involved in the development and marketing of drugs in areas that could compete with Aquestive's products.
AMGEN
AMGN
Mkt Cap233.78B
Amgen focuses on human therapeutics, including treatments in areas that overlap with Aquestive's focus, making them a competitor.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.46B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, competing with Aquestive in both market segments.
Biogen
BIIB
Mkt Cap32.28B
Biogen focuses on developing therapies for neurological and neurodegenerative diseases, potentially competing with Aquestive's CNS-focused treatments.

About

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
Show more...
CEO
Daniel Barber
Employees
147
Country
United States
ISIN
US03843E1047

Listings

BOATS
BOATS
AQST.BOATS
XNAS
US
AQST

0 Comments

Share your thoughts

FAQ

What is Aquestive Therapeutics stock price today?▼
The current price of AQST is $5.34 USD — it has decreased by -0.19% in the past 24 hours. Watch Aquestive Therapeutics stock price performance more closely on the chart.
What is Aquestive Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Aquestive Therapeutics stocks are traded under the ticker AQST.
Is Aquestive Therapeutics stock price growing?▼
AQST stock has risen by +6.37% compared to the previous week, the month change is a +42.78% rise, over the last year Aquestive Therapeutics has showed a +5.53% increase.
What is Aquestive Therapeutics market cap?▼
Today Aquestive Therapeutics has the market capitalization of 670.23M
When is the next Aquestive Therapeutics earnings date?▼
Aquestive Therapeutics is going to release the next earnings report on November 09, 2026.
What were Aquestive Therapeutics earnings last quarter?▼
AQST earnings for the last quarter are -0.18 USD per share, whereas the estimation was -0.11 USD resulting in a -71.43% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Aquestive Therapeutics revenue for the last year?▼
Aquestive Therapeutics revenue for the last year amounts to 44.55M USD.
What is Aquestive Therapeutics net income for the last year?▼
AQST net income for the last year is -83.78M USD.
How many employees does Aquestive Therapeutics have?▼
As of September 04, 2026, the company has 147 employees.
In which sector is Aquestive Therapeutics located?▼
Aquestive Therapeutics operates in the Health & Wellness sector.
When did Aquestive Therapeutics complete a stock split?▼
Aquestive Therapeutics has not had any recent stock splits.
Where is Aquestive Therapeutics headquartered?▼
Aquestive Therapeutics is headquartered in WARREN, United States.